Crystagen
Also called peptide bioregulator, EDP
Crystagen is one of the Khavinson short peptides - four amino acids long, from the same Russian bioregulator programme that produced Epitalon and Thymalin.
The published research here is animal and laboratory work. The ranges below come from community-reported dosing and results — what people have settled on in practice, and what they report happening.
- Immune
- Longevity & anti-aging
The quick answer
Crystagen is one of the Khavinson short peptides - four amino acids long, from the same Russian bioregulator programme that produced Epitalon and Thymalin. This one is aimed at immune function. Peptides this short are proposed to work at the level of which genes get read, rather than at a receptor on the cell surface.
What it is not
Not an acute immune booster, and not something to reach for once you already feel ill.
Why people use it
🛡️ Immune support that regulates rather than stimulates; 💊 Available as an oral capsule, not only an injection; 😌 Very well tolerated in reports; ⏱️ Short defined courses rather than continuous use
What people report using
These are ranges other people have reported running. They are here so you can see what has actually been done — they are not medical advice and not a recommendation for you.
- How often
- Daily for 10 days, then a break
- Route
- subcutaneous
- Evidence for this
- Animal and lab research
Immune reports similar to Thymalin, from a much smaller number of people.
What to expect, and when
A course of ten to twenty days, with effects described in the months afterward rather than during. Repeated seasonally.
Side effects, and what people do about them
Essentially none reported, consistent with the rest of the short-peptide family.
Go deeper
Open these only if you want them.
How it actually works
A tetrapeptide from the Khavinson short-peptide family. The bioregulator hypothesis holds that peptides this small can enter the cell and the nucleus and interact directly with DNA regions, influencing transcription in the tissue they are matched to. That is a distinctive claim, and nearly all the supporting work comes from one research group.
More on the evidence
Khavinson short-peptide bioregulator. Largely Russian-language literature.
The case against
The evidence is animal and cell work from a single research tradition and has not been independently replicated in the West. That tradition's longest human follow-up is on Thymalin and Epitalon, not on this one.
What people report, in full
Crystagen sits in the quieter corner of this space, discussed almost entirely inside the bioregulator community rather than in mainstream peptide forums. That community organises itself around courses - ten to twenty days, repeated seasonally - and Crystagen is usually described as the immune one in a rotation that also includes Epitalon and Thymalin. Reports are modest and consistent rather than dramatic: fewer minor infections, an easier winter. The oral form is a genuine draw and comes up often, since most of this category means an injection. The most useful thing that community says about the whole family is also the most honest: the effects are subtle, they build across courses, and anyone expecting to feel something on day three has misunderstood what these are for.
Sources and review
Everything above was written from the research and community reporting behind this compound, but we have not yet attached the citations. We would rather tell you that than let the page imply sources it does not have. This is being backfilled.
Last reviewed 2026-09-08.
People also look at
Still not sure?
Ask it the way you would ask a person. Follow-up questions are the point — it remembers what you already said.
Ask about Crystagen